Coral Laboratories Complete Financial Statements
CORALAB • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Coral Laboratories (CORALAB).
Downloads include all available records across all periods.
For market performance, see the
CORALAB stock price today
.
Profitability Ratios
Net Profit Margin
19.35%
2025 data
EBITDA Margin
28.23%
2025 data
Operating Margin
23.00%
2025 data
Return on Assets
10.43%
2025 data
Return on Equity
11.94%
2025 data
Balance Sheet Ratios
Current Ratio
59.00
2025 data
Debt to Equity
1.14
2025 data
Equity Ratio
87.39%
2025 data
Asset Turnover
0.54
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-20.2%
Year-over-Year
Net Profit Growth
-29.2%
Year-over-Year
EBITDA Growth
-28.6%
Year-over-Year
Expense Growth
-16.9%
Year-over-Year
Assets Growth
+11.7%
Year-over-Year
Equity Growth
+12.9%
Year-over-Year
Liabilities Growth
+11.7%
Year-over-Year
Operating Cash Flow Growth
+83.3%
Year-over-Year
Investing Cash Flow Growth
-100.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 99 | 124 | 90 | 85 | 80 | 100 | 77 | 96 | 97 | 99 | 80 | 62 |
| Expenses | 74 | 89 | 67 | 74 | 67 | 81 | 65 | 79 | 77 | 72 | 61 | 47 |
| EBITDA | 25 | 35 | 23 | 11 | 13 | 20 | 11 | 17 | 20 | 27 | 19 | 15 |
| Operating Profit Margin % | 18.00% | 23.00% | 19.00% | 5.00% | 11.00% | 16.00% | 8.00% | 13.00% | 16.00% | 24.00% | 21.00% | 21.00% |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 23 | 33 | 21 | 8 | 12 | 18 | 9 | 16 | 18 | 25 | 17 | 12 |
| Tax | 6 | 8 | 5 | 2 | 3 | 4 | 2 | 5 | 6 | 8 | 5 | 3 |
| Net Profit | 17 | 24 | 16 | 6 | 9 | 14 | 7 | 10 | 12 | 16 | 12 | 10 |
| Earnings Per Share (₹) | 48.60 | 67.61 | 44.19 | 18.04 | 25.32 | 37.94 | 19.96 | 28.60 | 34.84 | 45.61 | 34.70 | 26.79 |
Related Pages for Coral Laboratories
Additional stock information and data for CORALAB
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 230 | 206 | 174 | 190 | 168 | 144 | 136 | 140 | 131 | 90 | 72 |
| Current Assets | 177 | 154 | 124 | 131 | 129 | 96 | 84 | 72 | 74 | 65 | 50 |
| Fixed Assets | 23 | 24 | 25 | 24 | 21 | 23 | 23 | 22 | 18 | 18 | 19 |
| Capital Work in Progress | 3 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 52 | 50 | 41 | 46 | 33 | 25 | 28 | 45 | 39 | 0 | 0 |
| Other Assets | 152 | 132 | 108 | 118 | 112 | 97 | 85 | 73 | 74 | 71 | 54 |
| LIABILITIES | |||||||||||
| Total Liabilities | 230 | 206 | 174 | 190 | 168 | 144 | 136 | 140 | 131 | 90 | 72 |
| Current Liabilities | 3 | 3 | 8 | 8 | 3 | 4 | 4 | 4 | 4 | 1 | 1 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 201 | 178 | 155 | 156 | 137 | 116 | 114 | 116 | 109 | 70 | 59 |
| Share Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 198 | 174 | 151 | 153 | 133 | 112 | 110 | 113 | 106 | 67 | 56 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -1 | -6 | 13 | 6 | 1 | -4 | -1 | 14 | 11 | 5 | 0 |
| Investing Activities | 0 | 1 | -3 | -6 | 0 | -2 | 3 | -13 | -10 | -3 | -1 |
| Financing Activities | 3 | 0 | -6 | 0 | 0 | 4 | -1 | -3 | 1 | 0 | 0 |
| Net Cash Flow | 1 | -4 | 4 | 0 | 1 | -2 | 1 | -2 | 2 | 2 | 0 |